X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
60
PharmaCompass offers a list of Loxoprofen Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Loxoprofen Sodium manufacturer or Loxoprofen Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Loxoprofen Sodium manufacturer or Loxoprofen Sodium supplier.
PharmaCompass also assists you with knowing the Loxoprofen Sodium API Price utilized in the formulation of products. Loxoprofen Sodium API Price is not always fixed or binding as the Loxoprofen Sodium Price is obtained through a variety of data sources. The Loxoprofen Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Loxoprofen Sodium Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Loxoprofen Sodium Dihydrate, including repackagers and relabelers. The FDA regulates Loxoprofen Sodium Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Loxoprofen Sodium Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Loxoprofen Sodium Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Loxoprofen Sodium Dihydrate supplier is an individual or a company that provides Loxoprofen Sodium Dihydrate active pharmaceutical ingredient (API) or Loxoprofen Sodium Dihydrate finished formulations upon request. The Loxoprofen Sodium Dihydrate suppliers may include Loxoprofen Sodium Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Loxoprofen Sodium Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Loxoprofen Sodium Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Loxoprofen Sodium Dihydrate DMFs exist exist since differing nations have different regulations, such as Loxoprofen Sodium Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Loxoprofen Sodium Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Loxoprofen Sodium Dihydrate USDMF includes data on Loxoprofen Sodium Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Loxoprofen Sodium Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Loxoprofen Sodium Dihydrate Drug Master File in Japan (Loxoprofen Sodium Dihydrate JDMF) empowers Loxoprofen Sodium Dihydrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Loxoprofen Sodium Dihydrate JDMF during the approval evaluation for pharmaceutical products. At the time of Loxoprofen Sodium Dihydrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Loxoprofen Sodium Dihydrate Drug Master File in Korea (Loxoprofen Sodium Dihydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Loxoprofen Sodium Dihydrate. The MFDS reviews the Loxoprofen Sodium Dihydrate KDMF as part of the drug registration process and uses the information provided in the Loxoprofen Sodium Dihydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Loxoprofen Sodium Dihydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Loxoprofen Sodium Dihydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with KDMF on PharmaCompass.
A Loxoprofen Sodium Dihydrate written confirmation (Loxoprofen Sodium Dihydrate WC) is an official document issued by a regulatory agency to a Loxoprofen Sodium Dihydrate manufacturer, verifying that the manufacturing facility of a Loxoprofen Sodium Dihydrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Loxoprofen Sodium Dihydrate APIs or Loxoprofen Sodium Dihydrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Loxoprofen Sodium Dihydrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Loxoprofen Sodium Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Loxoprofen Sodium Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Loxoprofen Sodium Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Loxoprofen Sodium Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Loxoprofen Sodium Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Loxoprofen Sodium Dihydrate suppliers with NDC on PharmaCompass.
Loxoprofen Sodium Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Loxoprofen Sodium Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Loxoprofen Sodium Dihydrate GMP manufacturer or Loxoprofen Sodium Dihydrate GMP API supplier for your needs.
A Loxoprofen Sodium Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Loxoprofen Sodium Dihydrate's compliance with Loxoprofen Sodium Dihydrate specifications and serves as a tool for batch-level quality control.
Loxoprofen Sodium Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Loxoprofen Sodium Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Loxoprofen Sodium Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Loxoprofen Sodium Dihydrate EP), Loxoprofen Sodium Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Loxoprofen Sodium Dihydrate USP).
Market Place
